These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 34370045)
1. Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes. Miyata KN; Lo CS; Zhao S; Zhao XP; Chenier I; Yamashita M; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD Diabetologia; 2021 Nov; 64(11):2589-2601. PubMed ID: 34370045 [TBL] [Abstract][Full Text] [Related]
2. Tubular Deficiency of Heterogeneous Nuclear Ribonucleoprotein F Elevates Systolic Blood Pressure and Induces Glycosuria in Mice. Lo CS; Miyata KN; Zhao S; Ghosh A; Chang SY; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD Sci Rep; 2019 Oct; 9(1):15765. PubMed ID: 31673025 [TBL] [Abstract][Full Text] [Related]
3. Effect of renal tubule-specific knockdown of the Na Onishi A; Fu Y; Darshi M; Crespo-Masip M; Huang W; Song P; Patel R; Kim YC; Nespoux J; Freeman B; Soleimani M; Thomson S; Sharma K; Vallon V Am J Physiol Renal Physiol; 2019 Aug; 317(2):F419-F434. PubMed ID: 31166707 [TBL] [Abstract][Full Text] [Related]
4. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes. Lo CS; Shi Y; Chang SY; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS Diabetologia; 2015 Oct; 58(10):2443-54. PubMed ID: 26232095 [TBL] [Abstract][Full Text] [Related]
6. Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Abdo S; Lo CS; Chenier I; Shamsuyarova A; Filep JG; Ingelfinger JR; Zhang SL; Chan JS Diabetologia; 2013 Jul; 56(7):1649-60. PubMed ID: 23609310 [TBL] [Abstract][Full Text] [Related]
7. Knockout of Na Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127 [TBL] [Abstract][Full Text] [Related]
8. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Vallon V; Rose M; Gerasimova M; Satriano J; Platt KA; Koepsell H; Cunard R; Sharma K; Thomson SC; Rieg T Am J Physiol Renal Physiol; 2013 Jan; 304(2):F156-67. PubMed ID: 23152292 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Lo CS; Chang SY; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS Diabetes; 2012 Oct; 61(10):2597-608. PubMed ID: 22664958 [TBL] [Abstract][Full Text] [Related]
10. The tubular hypothesis of nephron filtration and diabetic kidney disease. Vallon V; Thomson SC Nat Rev Nephrol; 2020 Jun; 16(6):317-336. PubMed ID: 32152499 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice. Shi Y; Lo CS; Chenier I; Maachi H; Filep JG; Ingelfinger JR; Zhang SL; Chan JS Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1335-46. PubMed ID: 23552863 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging. Kidokoro K; Cherney DZI; Bozovic A; Nagasu H; Satoh M; Kanda E; Sasaki T; Kashihara N Circulation; 2019 Jul; 140(4):303-315. PubMed ID: 30773020 [TBL] [Abstract][Full Text] [Related]
13. A role for tubular Na Onishi A; Fu Y; Patel R; Darshi M; Crespo-Masip M; Huang W; Song P; Freeman B; Kim YC; Soleimani M; Sharma K; Thomson SC; Vallon V Am J Physiol Renal Physiol; 2020 Oct; 319(4):F712-F728. PubMed ID: 32893663 [TBL] [Abstract][Full Text] [Related]
14. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice. Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225 [TBL] [Abstract][Full Text] [Related]
15. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease. Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532 [TBL] [Abstract][Full Text] [Related]
16. Gene knockout of the Na Nespoux J; Patel R; Zhang H; Huang W; Freeman B; Sanders PW; Kim YC; Vallon V Am J Physiol Renal Physiol; 2020 May; 318(5):F1100-F1112. PubMed ID: 32116018 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice. Zhao S; Lo CS; Miyata KN; Ghosh A; Zhao XP; Chenier I; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD Diabetes; 2021 Jun; 70(6):1388-1403. PubMed ID: 33820760 [TBL] [Abstract][Full Text] [Related]
18. Renal Effects of Sodium-Glucose Co-Transporter Inhibitors. Thomson SC; Vallon V Am J Cardiol; 2019 Dec; 124 Suppl 1(Suppl 1):S28-S35. PubMed ID: 31741437 [TBL] [Abstract][Full Text] [Related]
19. Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus. Woods TC; Satou R; Miyata K; Katsurada A; Dugas CM; Klingenberg NC; Fonseca VA; Navar LG Am J Nephrol; 2019; 49(4):331-342. PubMed ID: 30921791 [TBL] [Abstract][Full Text] [Related]